Early Empiric Antibiotic Treatment Among Neonates With Congenital Heart Defects: A Brief Report of an Integrative Review

OBJECTIVES: Despite improved rates of survival, neonates with congenital heart defects experience serious comorbidities. Antibiotics are used widely in other critically ill neonates, and exposure in the first 7 days after birth (early empiric antibiotic treatment) has been associated with increased risk of adverse outcomes. The purpose of this brief report is to summarize and evaluate existing evidence pertaining to early empiric antibiotic treatment and associations with adverse outcomes among neonates with congenital heart defects. DESIGN: An integrative review of the literature was performed. SETTING: The search was conducted in PubMed and Ovid Medline, and Global Health databases. Medical Subject Headings terms and Boolean phrases were used. SUBJECTS: Original research articles were included if the study cohort neonates with congenital heart defects, were published in English, and included a description or evaluation of early empiric antibiotic treatment in the first 28 days of life. Endocarditis and postoperative antibiotic prophylaxis investigations were excluded. MAIN RESULTS: Our search generated 249 articles. Search results were listed in an Excel spreadsheet and screened by four authors. Articles that did not pertain to the population of interest were excluded. Fourteen articles were included in the full-text review. Data from these articles were summarized in a table and evaluated by all authors. No articles were found discussing early empiric antibiotic treatment in neonates with congenital heart defects. LIMITATIONS: Our search generated no results, impairing our ability to fulfill the purpose of the brief report. CONCLUSIONS: There have been no studies regarding early empiric antibiotic treatment among neonates with congenital heart defects. Research is needed to understand the prevalence, indications, and potential consequences of early empiric antibiotic treatment in this population.

[1]  Yi-jia Shao,et al.  Disorders of gut microbiota in children with Tetralogy of Fallot , 2021, Translational pediatrics.

[2]  Amber Price,et al.  Dysbiosis and Intestinal Barrier Dysfunction in Pediatric Congenital Heart Disease Is Exacerbated Following Cardiopulmonary Bypass , 2021, JACC. Basic to translational science.

[3]  E. Mayo-Wilson,et al.  The PRISMA 2020 statement: An updated guideline for reporting systematic reviews , 2021, PLoS medicine.

[4]  J. Neu,et al.  Antibiotics and the developing intestinal microbiome, metabolome and inflammatory environment in a randomized trial of preterm infants , 2020, Scientific Reports.

[5]  D. Steward,et al.  Patterns of Growth and Nutrition from Birth to 6-Months in Infants with Complex Congenital Cardiac Defects. , 2020, Nursing research.

[6]  L. Shekerdemian,et al.  Impact of feeding mode on neurodevelopmental outcome in infants and children with congenital heart disease. , 2019, Congenital heart disease.

[7]  L. Zühlke,et al.  Global birth prevalence of congenital heart defects 1970–2017: updated systematic review and meta-analysis of 260 studies , 2019, International journal of epidemiology.

[8]  A. Harabor,et al.  Prolonged use of antibiotics after birth is associated with increased morbidity in preterm infants with negative cultures , 2018, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[9]  Ashiqur Rahman,et al.  The Epidemiology of Healthcare-associated Infections in Pediatric Cardiac Intensive Care Units , 2017, The Pediatric infectious disease journal.

[10]  E. Gross,et al.  Antibiotic stewardship in the newborn surgical patient: A quality improvement project in the neonatal intensive care unit , 2017, Surgery.

[11]  H. Seiden,et al.  Brain injury with systemic inflammation in newborns with congenital heart disease undergoing heart surgery , 2017, Experimental and therapeutic medicine.

[12]  R. Mikolajczyk,et al.  Systemic inflammatory response syndrome after pediatric congenital heart surgery: Incidence, risk factors, and clinical outcome , 2017, Journal of cardiac surgery.

[13]  Rachael K. Ross,et al.  Identifying Antimicrobial Stewardship Targets for Pediatric Surgical Patients. , 2015, Journal of the Pediatric Infectious Diseases Society.

[14]  V. Pandit,et al.  Antibiotic Prescribing Pattern in a Tertiary Level Neonatal Intensive Care Unit. , 2015, Journal of clinical and diagnostic research : JCDR.

[15]  D. Redford,et al.  Clinical Characteristics Associated With Postoperative Intestinal Epithelial Barrier Dysfunction in Children With Congenital Heart Disease* , 2015, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[16]  Oktay Korun,et al.  Risk Factors for Systemic Inflammatory Response After Congenital Cardiac Surgery , 2015, Journal of cardiac surgery.

[17]  M. Honein,et al.  Pediatric inpatient hospital resource use for congenital heart defects. , 2014, Birth defects research. Part A, Clinical and molecular teratology.

[18]  D. Ward,et al.  Early empiric antibiotic use in preterm infants is associated with lower bacterial diversity and higher relative abundance of Enterobacter. , 2014, The Journal of pediatrics.

[19]  A. Correa,et al.  Temporal Trends in Survival Among Infants With Critical Congenital Heart Defects , 2013, Pediatrics.

[20]  Nicholas A. Bokulich,et al.  Probiotic Administration in Congenital Heart Disease: A Pilot Study , 2013, Journal of Perinatology.

[21]  J. Meinzen-Derr,et al.  Prolonged initial empirical antibiotic treatment is associated with adverse outcomes in premature infants. , 2011, The Journal of pediatrics.